Rimegepant
BHV3000-315
Phase 3 small_molecule active
Quick answer
Rimegepant for Migraine is a Phase 3 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Migraine
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active